Patheon is investing more than $3 million to expand its Greenville, North Carolina site’s stability testing capabilities.

The expansion includes the most advanced automated systems and assembly of a highly experienced scientific team to enhance its centralised stability lab offerings.

Since 2011, more than 1,000 stability studies with 110 different products have been initiated at Patheon’s stability lab in Greenville.

With this expansion, the facility offers more than 30,000 cubic feet of state-of-the-art stability storage, and the capabilities to support the largest, most complex projects.

These projects will be on small molecule APIs, large molecule biologics, drug substances, solid oral dose drugs, sterile liquid or lyophilised drugs, controlled substances and highly potent compounds.

Patheon executive director and global head of analytical sciences Bill Weiser, PhD said: "Our complete suite of advanced analytical tools dedicated to stability testing delivers accelerated results for customers’ late-stage development and commercial projects, providing high-quality data in 30 days or less.

"An additional benefit is that the stability lab’s high-tech chromatography system will be fully integrated with the data reporting system, which allows customers to access their data anytime, anywhere allowing for quicker access to submission ready reports."

Patheon is a recognised leader in quality, and the investment in its Greenville facility demonstrates the company’s commitment to continued growth and customer needs.

Companies facing costly upgrades to in-house stability capabilities will benefit greatly from the use of Patheon’s efficient and cost-effective centralised stability services.